Waymo Implements Temporary Pause on Robotaxi Operations in Five US Cities Following FloodRelated Incidents Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Hurdles Treasury Yield Surge Prompts Bond Investors to Explore Alternatives Beyond RiskFree Assets Fitness Apps Challenge Personal Trainer Industry Flexibility vs Risk Amazon Faces Allegations Over Millions in Revenue from NowIllegal Policy JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India TFCI What Investors Should Know WRLD Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Rallies CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66 NJR Q1 2026 Earnings EPS Surges Past Estimates with 14 Surprise Noble Corporation NE Q1 2026 Earnings EPS Beat on Operational Efficiency Stock Slightly Down JOUT Q1 2026 Earnings EPS Slightly Exceeds Expectations Amid Sparse Revenue Disclosure DAVE Q1 2026 Earnings EPS Beats Estimates by 37 Stock Declines on Lack of Revenue Details Telephone and Data Systems TDS Shares Dip 112 Amid Sector Headwinds Key Support Levels Tested Verra Mobility VRRM Climbs 09 as Stock Tests Resistance Near 1416 First Watch Restaurant Group FWRG Edges Lower as Support Holds Resistance Remains Key Hurdle NetSTREIT Corp NTST Continues to Slide Toward Key Support After 14 Decline Upexi Inc UPXI Slides 3 as Shares Test Key Support Near 123 TMO Q1 2026 Earnings EPS Surpasses Estimates by 284 Stock Edges Down ColgatePalmolive Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Operations PhenixFIN Corporation 525 Notes due 2028 PFXNZ Q1 2026 Earnings Strong EPS Beat of 2541 Surprise ODYS Q1 2026 Earnings WiderThanExpected Loss Pressures Shares GLPI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported INTA Q1 2026 Earnings Narrow EPS Beat Highlights Operational Discipline Amid Market Caution Fed Dissenters Voice Opposition to Rate Cut Hints in Latest Policy Statement NVAX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Edges Higher PDS Biotechnology PDSB Rises 345 as Stock Holds Above Key Support Level